Effect of Folic Acid Treatment in Coronary Artery Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2007 by University of Oxford.
Recruitment status was  Recruiting
British Heart Foundation
Information provided by:
University of Oxford
ClinicalTrials.gov Identifier:
First received: March 7, 2006
Last updated: August 6, 2008
Last verified: January 2007
We seek to examine the effects of folic acid treatment on vascular function in patients with coronary artery disease. Our hypothesis is that folic acid treatment will improve vascular function

Condition Intervention Phase
Coronary Artery Disease
Drug: Folic Acid
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Prevention
Official Title: Effect of Folic Acid Treatment in Coronary Artery Disease

Resource links provided by NLM:

Further study details as provided by University of Oxford:

Primary Outcome Measures:
  • Improvement in noninvasive measures of vascular function

Secondary Outcome Measures:
  • Improvement in laboratory measures of vascular function

Estimated Enrollment: 60
Study Start Date: May 2004
Primary Completion Date: May 2006 (Final data collection date for primary outcome measure)
Detailed Description:
Common vascular disease states including diabetes and atherosclerosis are associated with endothelial dysfunction, characterised by reduced bioactivity of nitric oxide (NO). Folates are thought to improve endothelial function,but the mechanism by which this effect occurs is poorly understood. We propose to study the effects of folate supplementation on endothelial function in patients with coronary artery disease.

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

Clinical diagnosis of coronary artery disease

Exclusion Criteria:

Recent acute coronary event Renal and/or hepatic dysfunction Metallic implants

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00300352

Contact: Cheerag C Shirodaria, MB BS MRCP +(44)1865-221866 cheerag.shirodaria@cardiov.ox.ac.uk

United Kingdom
University of Oxford Recruiting
Oxford, United Kingdom, OX3 9DU
Sponsors and Collaborators
University of Oxford
British Heart Foundation
Principal Investigator: Keith Channon, MD FRCP University of Oxford
  More Information

ClinicalTrials.gov Identifier: NCT00300352     History of Changes
Other Study ID Numbers: 04.OXB.004 
Study First Received: March 7, 2006
Last Updated: August 6, 2008
Health Authority: United Kingdom: Medicines and Healthcare Products Regulatory Agency

Keywords provided by University of Oxford:
Coronary artery disease
Folic acid
Endothelial function

Additional relevant MeSH terms:
Coronary Artery Disease
Coronary Disease
Myocardial Ischemia
Arterial Occlusive Diseases
Cardiovascular Diseases
Heart Diseases
Vascular Diseases
Folic Acid
Vitamin B Complex
Growth Substances
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on May 26, 2016